As of 2025-06-20, the Fair Value of Cardiol Therapeutics Inc (CRDL.TO) is -2.17 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.79 CAD, the upside of Cardiol Therapeutics Inc is -221.00%.
With the market price of 1.79 CAD and our fair value calculation, Cardiol Therapeutics Inc (CRDL.TO) is not a good investment. Investing in CRDL.TO stocks now will result in a potential loss of 221.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -20.64 | -31.64 | -30.93 | -28.13 | -36.68 | -29.60 |
| YoY growth | -50.88% | -53.29% | 2.24% | 9.06% | -30.39% | -24.65% |
| Market Cap (mil) | 147.87 |
| P/E | |
| Forward P/E |
| EPS | -0.43 |
| Avg earnings growth rate | -24.65% |
| TTM earnings | -35.79 |